CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS

CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS was reported 26 times

CHRONIC LYMPHOCYTIC INFLAMMATION WITH PONTINE PERIVASCULAR ENHANCEMENT RESPONSIVE TO STEROIDS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Glinide [EPC] 1 0.0001
1 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
2 Human Immunoglobulin G [EPC] 1 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
5 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
6 Glycopeptide Antibacterial [EPC] 1 0.0000
7 Alkylating Drug [EPC] 3 0.0000
8 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
9 Tumor Necrosis Factor Blocker [EPC] 10 0.0000
10 Corticosteroid [EPC] 12 0.0000
11 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
12 Microtubule Inhibitor [EPC] 1 0.0000
13 Platinum-based Drug [EPC] 1 0.0000
14 Osmotic Laxative [EPC] 1 0.0000
15 GLP-1 Receptor Agonist [EPC] 1 0.0000
16 Loop Diuretic [EPC] 1 0.0000
17 Kinase Inhibitor [EPC] 1 0.0000
18 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000